Sandoz Group AG (SDZXF)

OTCMKTS · Delayed Price · Currency is USD
94.55
+11.85 (14.33%)
At close: Feb 25, 2026
Market Cap40.36B +93.4%
Revenue (ttm)11.16B +7.4%
Net Income914.00M
EPS2.09
Shares Outn/a
PE Ratio44.16
Forward PE23.25
Dividend0.73 (0.85%)
Ex-Dividend DateApr 17, 2025
Volume2,661
Average Volume2,880
Open93.10
Previous Close82.70
Day's Range92.40 - 94.55
52-Week Range36.68 - 94.55
Beta0.26
RSI68.52
Earnings DateFeb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 20,000
Stock Exchange OTCMKTS
Ticker Symbol SDZXF
Full Company Profile

Financial Performance

Financial Statements